SARS-CoV-2

Tracking SARS-CoV-2 Variants

SARS-CoV-2 variants may seem like a scary new chapter in the pandemic, but coronavirus experts expected their arrival. Scientists in the UNC School of Medicine and Gillings School of Global Public Health are tracking the variants to learn how they differ and affect the world’s chance of ending this pandemic.

In It for the Long Haul

For some COVID-19 patients, the initial infection is just the start of the battle. Post-COVID syndrome occurs when a person's symptoms continue long after their infection ends. A new clinic at UNC hopes to not only help these patients, but also provide researchers with valuable data about this strange syndrome.

READDI, Not Reactive

For decades, scientists warned of the potential for a global coronavirus outbreak. But when SARS-CoV-2 emerged, no therapeutics, drugs, or vaccines were readily available. The Rapidly Emerging Antiviral Drug Development Initiative (READDI) — founded by researchers at UNC and the Structural Genomics Consortium — is not only finding solutions to the COVID-19 pandemic, but also drugs and therapeutics for future viral outbreaks.

Tackling COVID-19

As one of the first research facilities in the U.S. to receive a COVID-19 sample and begin testing for potential therapies, UNC’s response to the threat of the coronavirus was immediate and remains unyielding. While some of our researchers have been studying coronaviruses for years, many others have pivoted the focus of their research, refitted their labs, and are working collaboratively to better execute a holistic response to the pandemic.

Helping the Hardest Hit

While the novel coronavirus has affected us all, it has drastically changed the lives of specific groups of people, from rural populations to long-term care residents to communities of color. Startling statistics among these groups have pushed UNC researchers from a variety of disciplines into action.

Addressing Pandemic Problems

While COVID-19 has shaken the world, it has also pushed society to be more innovative and creative — two attributes that have been essential to the success of researchers at UNC. Carolina students, faculty, and staff are engaged in an abundance of projects, making UNC the most cited university in the nation for coronavirus research.

Doing COVID-19 Dirty Work

Employing wastewater epidemiology — proven useful in outbreaks of polio and opioid use — UNC microbiologist Rachel Noble is leading a state-wide collaboration tracking novel coronavirus outbreaks across North Carolina, gaining insight that testing individuals does not offer. Preliminary results have shown that by using wastewater, researchers can identify COVID-19 hot spots five to seven days before they are reflected by clinical testing results.

Expecting the Unexpected

After Myron Cohen watched the first patient at UNC Hospitals die from AIDS in 1982, he knew it was a disease to be reckoned with. He spent the next 40 years helping to recruit the most promising infectious disease experts from across the nation to build a program that’s become a leader in HIV. Today, UNC excels in understanding all aspects of HIV, from prevention to a potential cure — expertise that is now being used to tackle COVID-19.